PMID- 32716527 OWN - NLM STAT- MEDLINE DCOM- 20210818 LR - 20210818 IS - 1365-2265 (Electronic) IS - 0300-0664 (Linking) VI - 93 IP - 6 DP - 2020 Dec TI - Exendin-4-based imaging in endogenous hyperinsulinemic hypoglycaemia cohort: A tertiary Endocrine centre experience. PG - 678-686 LID - 10.1111/cen.14299 [doi] AB - CONTEXT: Insulinoma needs accurate preoperative localization for minimally invasive surgery. Exendin-4-based imaging has shown promising results. OBJECTIVE: To evaluate performance parameters of exendin-4-based imaging in insulinoma localization and compare with other imaging modalities. DESIGN: Retrospective cross-sectional study. PATIENTS: We report 14 patients with endogenous hyperinsulinemic hypoglycaemia (EHH) managed at our centre; in whom, the final diagnosis was insulinoma (n = 11), Munchausen syndrome (MS) (n = 2) and inconclusive (n = 1). Retrospective reporting of CECT, (68) Ga-DOTATATE PET/CT and (68) Ga-NODAGA-exendin-4-PET/CT was done. With per-lesion analysis, performance parameters were calculated for the histopathological diagnosis of insulinoma. MAIN OUTCOME MEASURES: True positive (TP), false positive (FP), false negative (FN), true negative (TN), sensitivity (Sn), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV) for insulinoma localization. RESULTS: In our cohort, 12 histopathologically proven insulinoma lesions [(TP): 11 primary lesions, 1 metastasis] were detected in 11 patients, whereas two patients had MS (TN). Sn and PPV were 75% and 100%, 33.3% and 80% and 83.3% and 71.4% for CECT, (68) Ga-DOTATATE PET/CT and (68) Ga-NODAGA-exendin-4-PET/CT, respectively. With exendin-4-based imaging, FP uptake in normal pancreatic tissue and FN results in the pancreatic tail lesion was seen. In one patient, TN result suggested the correct diagnosis of MS. CONCLUSION: (68) Ga-NODAGA-exendin-4-PET/CT has higher sensitivity than (68) Ga-DOTATATE PET/CT and CECT for insulinoma localization. FP uptake in normal pancreas and FN result in tail lesions are limitations of currently utilized exendin-4-based imaging. CI - (c) 2020 John Wiley & Sons Ltd. FAU - Garg, Robin AU - Garg R AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Shah, Ravikumar AU - Shah R AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Tiwari, Ankita AU - Tiwari A AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Purandare, Nilendu AU - Purandare N AD - Department of Radiodiagnosis and Imaging, Tata Memorial Center, Mumbai, India. FAU - Lele, Vikram R AU - Lele VR AD - Department of Nuclear Medicine & PET/CT, Jaslok Hospital & Research Center, Mumbai, India. FAU - Malhotra, Gaurav AU - Malhotra G AD - Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre, Annexe, India. FAU - Verma, Priyanka AU - Verma P AD - Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre, Annexe, India. FAU - Gosavi, Vikrant AU - Gosavi V AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Dalvi, Abhay AU - Dalvi A AD - Department of General Surgery, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Kumar Jaiswal, Sanjeet AU - Kumar Jaiswal S AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Patil, Virendra AU - Patil V AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Ramteke-Jadhav, Swati AU - Ramteke-Jadhav S AUID- ORCID: 0000-0003-1251-8918 AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Lila, Anurag AU - Lila A AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Shah, Nalini AU - Shah N AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. FAU - Bandgar, Tushar AU - Bandgar T AUID- ORCID: 0000-0002-6902-4639 AD - Department of Endocrinology, Seth GS Medical College & KEM Hospital, Parel, India. LA - eng PT - Journal Article DEP - 20200806 PL - England TA - Clin Endocrinol (Oxf) JT - Clinical endocrinology JID - 0346653 RN - 9P1872D4OL (Exenatide) SB - IM MH - *Congenital Hyperinsulinism MH - Cross-Sectional Studies MH - Exenatide MH - Humans MH - *Insulinoma/diagnostic imaging MH - *Pancreatic Neoplasms/diagnostic imaging MH - Positron Emission Tomography Computed Tomography MH - Retrospective Studies OTO - NOTNLM OT - Exendin-4 PET/CT OT - GLP-1 R imaging OT - endogenous hyperinsulinemic hypoglycaemia OT - insulinoma EDAT- 2020/07/28 06:00 MHDA- 2021/08/19 06:00 CRDT- 2020/07/28 06:00 PHST- 2020/06/03 00:00 [received] PHST- 2020/07/08 00:00 [revised] PHST- 2020/07/12 00:00 [accepted] PHST- 2020/07/28 06:00 [pubmed] PHST- 2021/08/19 06:00 [medline] PHST- 2020/07/28 06:00 [entrez] AID - 10.1111/cen.14299 [doi] PST - ppublish SO - Clin Endocrinol (Oxf). 2020 Dec;93(6):678-686. doi: 10.1111/cen.14299. Epub 2020 Aug 6.